How soon after starting Wegovy do you lose weight?

The first few weeks: something is changing, but slowly

Picture the scene: you've injected your first 0.25 mg dose on a Sunday evening, and by Wednesday you're already wondering whether it's working. Something feels different (meals feel heavier, snacks seem less urgent) but the number on the scales hasn't shifted much. That's normal, and it makes sense once you understand what the starter dose is actually doing.

The 0.25 mg starting strength exists to let your body adjust to the medicine, not to produce weight loss. Nausea and other gut symptoms are more likely at higher doses, so the schedule begins low and climbs slowly. During weeks one to four, most people report a noticeable drop in appetite and, often, a small reduction in weight (sometimes two to four pounds) driven partly by reduced food intake and partly by changes in fluid retention. If you're curious about how soon you start losing weight on Wegovy, that early signal is a genuine sign the medicine is working, though it is not representative of the pace you'll see later.

Our guide to starting Wegovy covers what those early weeks tend to feel like in practice, including the side effects that are most common at the outset.

Months two to five: the dose rises, and so does the effect

Wegovy's licensed titration pathway moves from 0.25 mg to 0.5 mg after four weeks, then 1.0 mg, then 1.7 mg, reaching the 2.4 mg maintenance dose around month five — each step taken roughly four weeks apart under prescriber guidance. As the dose climbs, GLP-1 receptor activity in the brain intensifies, hunger signals quieten further, and energy intake falls more consistently.

This is where weight loss typically accelerates, and understanding how soon you lose weight on Wegovy helps set realistic expectations, since by the end of month three many people have lost five to eight percent of their starting weight, and by month six ten percent or more is common among those tolerating the dose increases well. The STEP 1 trial, published in the New England Journal of Medicine, found an average loss of around 15% of body weight over 68 weeks, that figure represents the end point of a slow, compounding process, not a sudden drop.

A practical note: if you are timing your first order around a payday or a holiday abroad, it is worth knowing that the dose-review process is built into regular check-ins with your prescriber, so planning a few weeks ahead matters more than most people expect.

For a closer look at the evidence behind these figures, the Wegovy updates page covers trial data and the latest regulatory news, including the approved higher 7.2 mg dose.

Six months and beyond: where long-term results are made

The largest share of total weight loss on Wegovy tends to happen between months three and twelve. After reaching the maintenance dose, weight continues to fall (gradually) as the body adjusts its set point over time. The 15% average from STEP 1 was measured at 68 weeks (roughly 16 months), meaning sustained use and lifestyle changes alongside treatment are what produce the headline results.

It is also worth knowing that weight loss is not linear. Plateaus are common, particularly around months four to six, and do not necessarily mean the medicine has stopped working. A prescriber can help distinguish a true plateau from one that resolves with continued treatment or a lifestyle adjustment. If weight loss is less than five percent after six months at the maintenance dose, NICE's appraisal of semaglutide (TA875) notes that continuing should be reviewed clinically.

Questions about what to expect at each stage of treatment, or how Wegovy compares to other licensed options, are exactly what the prescribers at our clinical team handle during consultations. There is no script to follow; every review looks at your specific situation.

Why the pace differs between people

Two people can follow the same Wegovy schedule and see very different timelines. Starting weight matters: someone with a higher BMI often sees a larger absolute loss in the early months, even if the percentage is similar. Adherence to dose increases, how the gut tolerates each step up, protein intake, sleep, stress and activity level all shape the rate. Semaglutide slows gastric emptying (that is central to how it reduces appetite) but the degree of that effect varies between individuals.

Age, hormonal status and any other medicines you take can also influence results, which is why a full clinical review before starting is not a formality. It is the point at which a prescriber can flag interactions, adjust expectations and tailor the plan. You can read more about how semaglutide works at a pharmacological level, or explore how Wegovy sits alongside other weight-loss medicine options on the weight management overview page.

If you are weighing up cost alongside timing (since private treatment is a commitment over several months) the Wegovy sourcing and cost page explains what legitimate private pricing typically includes and why the supply chain matters for a prescription medicine.

When you are ready to find out whether Wegovy is clinically appropriate for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.